Market Trends Insmed issues preliminary revenue results, guidance for ArikayceBy admin8996erT0allJanuary 10, 2025 jurgenfrInsmed (NASDAQ:INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. The drugmaker said 2024…
